That's one of the more realistic and level headed posts I've seen regarding UNI for a while. I agree with regards to the 1ml, the company has pretty much flagged that they will need the full clinical range before they can make any significant inroads, I think we will see some minor sales orders and the rest will be deals with distributors.
The main thing I will be waiting for is to see the manufacturing capacity filled, throughout the year I'd like to know that come the end of 2010 we have customers waiting with pending orders and 60m units will be produced throughout 2011, I'll then be awaiting news that clarifies the additional line of 150m units pa is to be filled with pending orders also. So on and so forth for the years after that.
The deals with other pharma is the one to watch for me through 2010 and cemented nearer term orders to fill capacity. Also other deals that the company has flagged in the past with regards to some contract work that has been happening, there was talk of something with B.Braun.
Add to My Watchlist
What is My Watchlist?
